Drug Shortage Report for ZARONTIN SYRUP
| Report ID | 156287 |
| Drug Identification Number | 00023485 |
| Brand name | ZARONTIN SYR 250MG/5ML |
| Common or Proper name | ZARONTIN SYRUP |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHOSUXIMIDE |
| Strength(s) | 250MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL ORAL |
| Packaging size | 473ML |
| ATC code | N03AD |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-02-10 |
| Actual start date | 2022-02-12 |
| Estimated end date | 2022-05-15 |
| Actual end date | 2022-05-17 |
| Shortage status | Resolved |
| Updated date | 2022-05-18 |
| Company comments | ZAROTIN CAPSULES AVAILABLE |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-05-18 | English | Compare |
| v6 | 2022-05-17 | French | Compare |
| v5 | 2022-05-17 | English | Compare |
| v4 | 2022-05-04 | French | Compare |
| v3 | 2022-05-04 | English | Compare |
| v2 | 2022-03-08 | French | Compare |
| v1 | 2022-03-08 | English | Compare |
Showing 1 to 7 of 7